Nodality (San Francisco, CA) a development-stage molecular diagnostics company focused on hematological malignancies and autoimmune disorders, closed a $15.5M Series D financing. Participants include Pfizer Venture Investments, Laboratory Corp of America Holdings, Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Growth.